86 related articles for article (PubMed ID: 22399594)
1. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594
[TBL] [Abstract][Full Text] [Related]
2. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
[TBL] [Abstract][Full Text] [Related]
3. Detection of TFPI2 methylation in the serum of gastric cancer patients.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206
[TBL] [Abstract][Full Text] [Related]
4. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.
Hibi K; Goto T; Kitamura YH; Yokomizo K; Sakuraba K; Shirahata A; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2010 Apr; 30(4):1205-7. PubMed ID: 20530429
[TBL] [Abstract][Full Text] [Related]
5. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.
Zhang J; Yang S; Xie Y; Chen X; Zhao Y; He D; Li J
Cancer Epidemiol; 2012 Feb; 36(1):73-7. PubMed ID: 21621497
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
7. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.
Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Yokomizo K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2011 Sep; 31(9):2889-92. PubMed ID: 21868534
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
[TBL] [Abstract][Full Text] [Related]
10. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT
Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772
[TBL] [Abstract][Full Text] [Related]
11. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients.
Sakakura C; Hamada T; Miyagawa K; Nishio M; Miyashita A; Nagata H; Ida H; Yazumi S; Otsuji E; Chiba T; Ito K; Ito Y
Anticancer Res; 2009 Jul; 29(7):2619-25. PubMed ID: 19596937
[TBL] [Abstract][Full Text] [Related]
14. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
Takada H; Wakabayashi N; Dohi O; Yasui K; Sakakura C; Mitsufuji S; Taniwaki M; Yoshikawa T
Cancer Genet Cytogenet; 2010 Feb; 197(1):16-24. PubMed ID: 20113832
[TBL] [Abstract][Full Text] [Related]
16. p16INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer.
Nakayama G; Kodera Y; Ohashi N; Koike M; Fujiwara M; Nakao A
Anticancer Res; 2011 May; 31(5):1643-6. PubMed ID: 21617221
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
18. FBN2 methylation is detected in the serum of colorectal cancer patients with hepatic metastasis.
Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2012 Oct; 32(10):4371-4. PubMed ID: 23060561
[TBL] [Abstract][Full Text] [Related]
19. Vimentin methylation as a marker for advanced colorectal carcinoma.
Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
[TBL] [Abstract][Full Text] [Related]
20. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients.
Nakayama G; Hibi K; Nakayama H; Kodera Y; Ito K; Akiyama S; Nakao A
Anticancer Res; 2007; 27(3B):1459-63. PubMed ID: 17595762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
